Characterization of probiotic bacterial cells enzyme activity, investigation of their gastrointestinal stability and impact on microbiota composition and function.
益生菌细胞酶活性的表征,研究其胃肠道稳定性以及对微生物群组成和功能的影响。
基本信息
- 批准号:523227-2018
- 负责人:
- 金额:$ 0.91万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Engage Plus Grants Program
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Probiotics are living, active microorganisms that, when ingested in certain quantities, confer significant health**benefits. Biena is a company specialized in dairy cultures, enzymes and probiotics. Biena has isolated several**natural probiotic bacterial strains and would like to develop various probiotic health formulations based on**bacterial cells enzymatic activities. Specifically Biena is looking to isolate and characterize bacterial cells for**human health benefits based on Ferulic Acid Esterase active bacterial strains. Biena lacks infrastructure and**expertise to characterize these bacterial cells for their enzymatic activities and investigate their stability in GI**transit and impact of those bacterial cells on gut bacterial population for which they approached Dr. Prakash's**lab at McGill University which has NSERC funded computer-controlled simulated human dynamic**gastrointestinal model, the only model of its kind in Canada and expertise in the field. This NSERC Engage**Plus Grant application is an extension of the existing NSERC Engage Grant between Beina and McGill**University. In this proposal characterization of probiotic bacterial cells enzyme activity, gastrointestinal**stability and impact on microbiota composition and function will be carried out. These investigations will**provide development of health food probiotic products and opportunities for collaborations.
益生菌是活的,活跃的微生物,当摄入一定数量时,会带来显着的健康益处。Biena是一家专门从事乳制品培养,酶和益生菌的公司。Biena已经分离出几种 ** 天然益生菌菌株,并希望开发基于 ** 细菌细胞酶活性的各种益生菌健康配方。具体来说,Biena正在寻求分离和表征基于阿魏酸酯酶活性菌株的细菌细胞,以 ** 人类健康益处。Biena缺乏基础设施和专业知识来表征这些细菌细胞的酶活性,并研究它们在GI** 运输中的稳定性以及这些细菌细胞对肠道细菌种群的影响,为此他们联系了麦吉尔大学的Prakash博士的实验室,该实验室拥有NSERC资助的计算机控制的模拟人体动态胃肠模型,这是加拿大唯一的同类模型和该领域的专业知识。此NSERC Engage**Plus Grant申请是Beina和麦吉尔 **University之间现有NSERC Engage Grant的扩展。在该提案中,将进行益生菌细胞酶活性、胃肠道 ** 稳定性以及对微生物群组成和功能的影响的表征。这些研究将为健康食品益生菌产品的开发和合作提供机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prakash, Satya其他文献
PAMAM Dendrimer-Baculovirus Nanocomplex for Microencapsulated Adipose Stem Cell-Gene Therapy: In Vitro and in Vivo Functional Assessment
- DOI:
10.1021/mp3000502 - 发表时间:
2012-09-01 - 期刊:
- 影响因子:4.9
- 作者:
Paul, Arghya;Shao, Wei;Prakash, Satya - 通讯作者:
Prakash, Satya
Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase η in translesion DNA synthesis
- DOI:
10.1073/pnas.0809844105 - 发表时间:
2008-11-18 - 期刊:
- 影响因子:11.1
- 作者:
Acharya, Narottam;Yoon, Jung-Hoon;Prakash, Satya - 通讯作者:
Prakash, Satya
Analysis of Blood Group Discrepancy in Healthy Blood Donors at a Tertiary Care Referral Hospital from Eastern India: A Retrospective Study.
- DOI:
10.1055/s-0042-1742417 - 发表时间:
2022-09 - 期刊:
- 影响因子:1.1
- 作者:
Sahu, Ansuman;Prakash, Satya;Das, Niladri;Routray, Suman Sudha;Naik, Archana;Mukherjee, Somnath - 通讯作者:
Mukherjee, Somnath
Evaluation of cyclic hot corrosion behaviour of detonation gun sprayed Cr3C2-25%NiCr coatings on nickel- and iron-based superalloys
- DOI:
10.1016/j.surfcoat.2008.09.031 - 发表时间:
2009-01-15 - 期刊:
- 影响因子:5.4
- 作者:
Kamal, Subhash;Jayaganthan, R.;Prakash, Satya - 通讯作者:
Prakash, Satya
Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules
- DOI:
10.1021/mp049901v - 发表时间:
2005-01-01 - 期刊:
- 影响因子:4.9
- 作者:
Haque, Tasima;Chen, Hongmei;Prakash, Satya - 通讯作者:
Prakash, Satya
Prakash, Satya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prakash, Satya', 18)}}的其他基金
Nanomaterial impacts on the gastrointestinal microbiome.
纳米材料对胃肠道微生物群的影响。
- 批准号:
RGPIN-2019-06596 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Nanomaterial impacts on the gastrointestinal microbiome.
纳米材料对胃肠道微生物群的影响。
- 批准号:
RGPIN-2019-06596 - 财政年份:2021
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Nanomaterial impacts on the gastrointestinal microbiome.
纳米材料对胃肠道微生物群的影响。
- 批准号:
RGPIN-2019-06596 - 财政年份:2020
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Nanomaterial impacts on the gastrointestinal microbiome.
纳米材料对胃肠道微生物群的影响。
- 批准号:
RGPIN-2019-06596 - 财政年份:2019
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Nanomaterial impacts on gastrointestinal microbiome.
纳米材料对胃肠道微生物组的影响。
- 批准号:
RGPIN-2018-06364 - 财政年份:2018
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Carbon nanotube bacterial cell interactions: development of carbon nanotube formulations for targeted destruction of pathogenic antibiotic resistant bacterial cells.
碳纳米管细菌细胞相互作用:开发碳纳米管制剂,用于有针对性地破坏致病性抗生素耐药细菌细胞。
- 批准号:
239094-2012 - 财政年份:2017
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Characterization of probiotic bacterial cells enzyme activity and investigation of their gastrointestinal stability and impact on microbiota composition and function
益生菌细胞酶活性的表征及其胃肠道稳定性及其对微生物群组成和功能的影响的研究
- 批准号:
508091-2016 - 财政年份:2016
- 资助金额:
$ 0.91万 - 项目类别:
Engage Grants Program
Carbon nanotube bacterial cell interactions: development of carbon nanotube formulations for targeted destruction of pathogenic antibiotic resistant bacterial cells.
碳纳米管细菌细胞相互作用:开发碳纳米管制剂,用于有针对性地破坏致病性抗生素耐药细菌细胞。
- 批准号:
239094-2012 - 财政年份:2015
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Carbon nanotube bacterial cell interactions: development of carbon nanotube formulations for targeted destruction of pathogenic antibiotic resistant bacterial cells.
碳纳米管细菌细胞相互作用:开发碳纳米管制剂,用于有针对性地破坏致病性抗生素耐药细菌细胞。
- 批准号:
239094-2012 - 财政年份:2014
- 资助金额:
$ 0.91万 - 项目类别:
Discovery Grants Program - Individual
Feasibility evaluation of engineered albucore nanoparticles for drug encapsulation.
用于药物封装的工程白蛋白纳米颗粒的可行性评估。
- 批准号:
474295-2014 - 财政年份:2014
- 资助金额:
$ 0.91万 - 项目类别:
Engage Grants Program
相似国自然基金
微生物源Tri101基因在玉米中表达和毒理分析
- 批准号:30771439
- 批准年份:2007
- 资助金额:8.0 万元
- 项目类别:面上项目
益生性乳杆菌的耐受性和定植作用机制研究
- 批准号:30670057
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Treatment of Recurrent Bacterial Vaginosis Using Engineered Probiotic Bacteria
使用工程益生菌治疗复发性细菌性阴道病
- 批准号:
10035355 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Collaborative R&D
Brewing anti-toxin drugs using probiotic yeast
利用益生菌酵母酿造抗毒素药物
- 批准号:
10687670 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Investigating the effects of psychosocial stress on laryngeal microbiology and epithelial barrier integrity
研究社会心理压力对喉部微生物学和上皮屏障完整性的影响
- 批准号:
10824680 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Hypoxia-activated probiotic agents for breast cancer
用于乳腺癌的缺氧激活益生菌制剂
- 批准号:
10660233 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
The Gut-Liver Axis in HIV-Related Non-Alcoholic Fatty Liver Disease
HIV 相关非酒精性脂肪肝中的肠肝轴
- 批准号:
10762284 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Optimizing the vaginal microbiome In African, Caribbean and other Black women from Toronto, Canada: defining clinical endpoints and community priorities
优化来自加拿大多伦多的非洲、加勒比和其他黑人女性的阴道微生物组:确定临床终点和社区优先事项
- 批准号:
494152 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Operating Grants
Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability
鉴定用于开发口服益生菌的菌株,旨在提高一氧化氮的生物利用度
- 批准号:
10666185 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Bacterial mediators of postnatal growth in preterm infants
早产儿产后生长的细菌介质
- 批准号:
10572371 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
Human gut bacterial cell surface polysaccharides as a microbial nutrient source and target of immunoregulatory proteins shape gut microbiota structure and function
人肠道细菌细胞表面多糖作为微生物营养源和免疫调节蛋白的靶标塑造肠道微生物群的结构和功能
- 批准号:
10811932 - 财政年份:2023
- 资助金额:
$ 0.91万 - 项目类别:
A Novel Probiotic Drug Delivery Platform for Oral Administration of Protein-Based Therapies
用于口服蛋白质疗法的新型益生菌药物递送平台
- 批准号:
10544376 - 财政年份:2022
- 资助金额:
$ 0.91万 - 项目类别: